drugset
Drugs / unoprostone isopropyl
last change Apr 2015 re-read 3 minutes ago

unoprostone isopropyl

also known as Isopropyl unoprostone · Rescula · UF-021 · Unoprostone isopropyl ester

Small molecule

Developed for
dry age related macular degeneration · retinitis pigmentosa
Investigated by
R-Tech Ueno, Ltd. · Sucampo Pharma Americas, LLC · Sucampo Pharmaceuticals, Inc.

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) RESCULA — 2000-08-03 fda.gov ↗

Trials 2

today
US approved 2000
NCT01786395 · Ph 3 NCT01379560 · Ph 2
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT01379560 May → Dec 2011 dry age related macular degeneration Sucampo Pharma Americas, LLC Completed No outcome recorded
Phase 31 trial
Phase 3 NCT01786395 Mar 2013 → Apr 2015 retinitis pigmentosa R-Tech Ueno, Ltd. Terminated No outcome recorded

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as unoprostone isopropyl ClinicalTrials.gov intervention name — accepted as the source's own label NCT01379560 ↗
Known as Isopropyl unoprostone ChEMBL registry synonym — accepted as the source's own label CHEMBL1200661 ↗
Known as Rescula ChEMBL registry synonym — accepted as the source's own label CHEMBL1200661 ↗
Known as UF-021 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01786395 ↗
Known as Unoprostone isopropyl ester ChEMBL registry synonym — accepted as the source's own label CHEMBL1200661 ↗
Modality Small molecule — CHEMBL1200661 ↗